Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Katarína Hadová"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 9, p 1139 (2024)
Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist. GLP-1R agonists are used to treat type 2 diabetes and obesity. It is currently unknown whether semaglutide can directly increase force of contraction (FOC) in the human heart. We tes
Externí odkaz:
https://doaj.org/article/6a78d4276bc04006af37dc53873a16f3
Autor:
Neumann, Joachim1 (AUTHOR) joachim.neumann@medizin.uni-halle.de, Hadová, Katarína2 (AUTHOR) hadova@fpharm.uniba.sk, Klimas, Jan2 (AUTHOR) klimas1@uniba.sk, Hofmann, Britt3 (AUTHOR) britt.hofmann@uk-halle.de, Gergs, Ulrich1 (AUTHOR)
Publikováno v:
Pharmaceutics. Sep2024, Vol. 16 Issue 9, p1139. 13p.